Physician profile
Scott Clements
NPI 1649478512
$12,895.43
in general payments reported to CMS, 2019-2025
12 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,281 · 2021: $135 · 2022: $215 · 2023: $58.31 · 2024: $576 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $1,377 · Honoraria: $775 · Travel and Lodging: $601 · Education: $11.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $1,377.24 |
| Honoraria | $775.00 |
| Travel and Lodging | $600.61 |
| Education | $11.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Soleno Therapeutics, INC. | $9,450.86 | 2025 | Vykat Xr |
| Medtronic Minimed, INC. | $1,166.13 | 2019 | |
| Chiesi USA, INC. | $775.00 | 2025 | Myalept |
| Abbott Laboratories | $315.73 | 2021-2022 | |
| Medtronic, INC. | $303.71 | 2022-2025 | Minimed 780g |
| Pfizer INC. | $247.83 | 2024 | |
| Dexcom, INC. | $188.79 | 2019-2025 | Dexcom G6 Transmitter |
| Tolmar, INC. | $114.86 | 2025 | Fensolvi |
| Alexion Pharmaceuticals, INC. | $103.92 | 2024 | Strensiq |
| Insulet Corporation | $98.33 | 2019 | |
| Beta Bionics, INC. | $91.50 | 2024 | Ilet Bionic Pancreas |
| Tandem Diabetes Care, INC. | $38.77 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.